Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-26-000017
Filing Date
2026-07-30
Accepted
2026-07-30 16:32:59
Documents
86
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20260630x10q.htm   iXBRL 10-Q 2938523
2 EX-31.1 tmb-20260630xex31d1.htm EX-31.1 10858
3 EX-31.2 tmb-20260630xex31d2.htm EX-31.2 10669
4 EX-32.1 tmb-20260630xex32d1.htm EX-32.1 5879
5 EX-32.2 tmb-20260630xex32d2.htm EX-32.2 6069
  Complete submission text file 0001070081-26-000017.txt   13756550

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20260630.xsd EX-101.SCH 82608
7 EX-101.CAL tmb-20260630_cal.xml EX-101.CAL 76856
8 EX-101.DEF tmb-20260630_def.xml EX-101.DEF 400505
9 EX-101.LAB tmb-20260630_lab.xml EX-101.LAB 732862
10 EX-101.PRE tmb-20260630_pre.xml EX-101.PRE 556880
92 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20260630x10q_htm.xml XML 3017829
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 261223879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)